Malla, Tika R. https://orcid.org/0000-0003-4989-6410
Tumber, Anthony
John, Tobias https://orcid.org/0000-0002-6123-595X
Brewitz, Lennart https://orcid.org/0000-0002-9465-777X
Strain-Damerell, Claire https://orcid.org/0000-0003-4964-2090
Owen, C David https://orcid.org/0000-0001-5774-8202
Lukacik, Petra https://orcid.org/0000-0002-3179-7273
Chan, H. T. Henry https://orcid.org/0000-0001-8838-6136
Maheswaran, Pratheesh https://orcid.org/0000-0002-3745-9603
Salah, Eidarus
Duarte, Fernanda https://orcid.org/0000-0002-6062-8209
Yang, Haitao
Rao, Zihe
Walsh, Martin A. https://orcid.org/0000-0001-5683-1151
Schofield, Christopher J. https://orcid.org/0000-0002-0290-6565
Funding for this research was provided by:
Cancer Research UK
Engineering and Physical Sciences Research Council (EP/R512060/1, EP/L015838/1)
Wellcome Trust
Medical Research Council
Biotechnology and Biological Sciences Research Council (BB/M011224/1)
GlaxoSmithKline
RELATED DATA
IDENTIFIERS
: Claire Strain-Damerell (ORCID)
: Pratheesh Maheswaran (ORCID)
PEER REVIEW METHOD
: Authors can choose between single-blind and double-blind peer review
PUBLICATION HISTORY
: Received 14 October 2020; Accepted 23 November 2020; Advance Article published 19 January 2021; Version of Record published 15 February 2021